Cargando…

Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems

BACKGROUND: ESBL (Extended spectrum beta-lactamase) producing enterobacteriaceae are challenging organisms with little treatment options. Carbapenems are frequently used, but the emergence of carbapenem resistant enterobacteriaceae is a concerning issue, which may hinder the use of carbapenems. Alth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukuchi, Takahiko, Iwata, Kentaro, Kobayashi, Saori, Nakamura, Tatsuya, Ohji, Goh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991070/ https://www.ncbi.nlm.nih.gov/pubmed/27538488 http://dx.doi.org/10.1186/s12879-016-1770-1

Ejemplares similares

Bactericidal efficacy of meropenem in combination with cefmetazole against IMP-producing carbapenem-resistant Enterobacteriaceae
por: Abe, Ryuichiro, et al.
Publicado: (2019)

Efficacy and Safety of Cefmetazole for Bacteremia Caused by Extended-Spectrum β-Lactamase–Producing Enterobacterales vs Carbapenems: A Retrospective Study
por: Kashihara, Eriko, et al.
Publicado: (2023)

Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains
por: Ito, Ryota, et al.
Publicado: (2022)

ESBL- and Carbapenemase-Producing Enterobacteriaceae in Patients with Bacteremia, Yangon, Myanmar, 2014
por: Myat, Tin O., et al.
Publicado: (2017)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

Failure of Early Diagnosis of Infective Endocarditis in Japan—A Retrospective Descriptive Analysis
por: Fukuchi, Takahiko, et al.
Publicado: (2014)

518. Comparing the Mortality of Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia
por: Seo, Hyeonji, et al.
Publicado: (2019)

A Response to Research Article “Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022)

1508. Carbapenem vs. Non-carbapenem as Empiric Regimens for Bacteremia Caused by ESBL Producing Escherichia coli and Klebsiella pneumoniae in Children: Preliminary Study
por: Park, Saera, et al.
Publicado: (2019)

The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from Sputum
por: Goto, Akihiko, et al.
Publicado: (2021)

Prevalence of ESBL-producing Enterobacteriaceae in raw vegetables
por: Reuland, E. A., et al.
Publicado: (2014)

A systematic review for pursuing the presence of antibiotic associated enterocolitis caused by methicillin resistant Staphylococcus aureus
por: Iwata, Kentaro, et al.
Publicado: (2014)

658. Evaluation of Effectiveness of Cefmetazole vs Meropenem for Invasive Urinary Tract Infections Caused by ESBL-Producing Escherichia coli: A Prospective Multicenter Observational Study
por: Hayakawa, Kayoko, et al.
Publicado: (2022)

Reply: The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from Sputum
por: Kang, Cheol-In
Publicado: (2021)

2442. Outcomes in ESBL Bacteremia Empirically Treated With Piperacillin/Tazobactam or Carbapenems
por: John, Reeba, et al.
Publicado: (2018)

Pharmacokinetic–pharmacodynamic analysis of cefmetazole against extended-spectrum β-lactamase-producing Enterobacteriaceae in dogs using Monte Carlo Simulation
por: Kusumoto, Mizuki, et al.
Publicado: (2023)

Endogenous Bacteremia Caused by Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae (CRE) in Immunocompromised Children
por: Almasian Tehrani, Nasim, et al.
Publicado: (2023)

Pediatric Febrile Urinary Tract Infection Caused by ESBL Producing Enterobacteriaceae Species
por: Agegnehu, Asnakech, et al.
Publicado: (2020)

Molecular Characterization of ESBL-Producing Enterobacteriaceae in Northern Portugal
por: Fernandes, Rúben, et al.
Publicado: (2014)

Rapid Detection of ESBL-Producing Enterobacteriaceae in Blood Cultures
por: Dortet, Laurent, et al.
Publicado: (2015)

1055. Epidemiology and Mechanisms of Carbapenem Resistance in Recurrent Extended-Spectrum β-Lactamase- Producing Enterobacteriaceae Bacteremia
por: Aitken, Samuel L, et al.
Publicado: (2018)

211. Disease burden of bacteremia with extended-spectrum beta-lactamase-producing or carbapenem-resistant Enterobacteriaceae in Korea
por: Mi Lee, Chan, et al.
Publicado: (2023)

Overview of ESBL-producing Enterobacteriaceae from a Nordic perspective
por: Brolund, Alma
Publicado: (2014)

Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam
por: Reuland, E. A., et al.
Publicado: (2016)

Combination Therapy with Aminoglycoside in Bacteremiasdue to ESBL-Producing Enterobacteriaceae in ICU
por: Benetazzo, Lucie, et al.
Publicado: (2020)

479 Clinical outcomes in patients with extended-spectrum-beta-lactamase-producing (ESBL) Enterobacteriaceae bloodstream infections (ESB) treated with carbapenems (CP) and non-carbapenems (NC)
por: Chin, Judy, et al.
Publicado: (2014)

Carbapenem-Sparing Strategies for ESBL Producers: When and How
por: Karaiskos, Ilias, et al.
Publicado: (2020)

1826. Impact of Rapid Diagnostics and Ceftazidime–Avibactam on Mortality after Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae
por: Satlin, Michael J, et al.
Publicado: (2019)

260 Ceftolozane/Tazobactam for the Treatment of cUTI and cIAI Caused by ESBL-producing Enterobacteriaceae
por: Popejoy, Myra, et al.
Publicado: (2014)

Factors Associated with Mortality in Carbapenem-Resistant Enterobacteriaceae Bacteremia: Focus on Antibiotic Therapy
por: Pillinger, Kelly E, et al.
Publicado: (2017)

Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant Enterobacteriaceae?
por: Alhashem, Fatema, et al.
Publicado: (2017)

Prevalence of carriage of ESBL producing enterobacteriaceae in a Dutch teaching hospital
por: Moen, G, et al.
Publicado: (2011)

Carbapenem-Resistant and ESBL-Producing Enterobacterales Emerging in Central Texas
por: Parker, Jennifer K, et al.
Publicado: (2023)

434 Prevalence, Risk Factors, and Outcomes of Bacteremia Caused by Carbapenem-resistant Enterobacteriaceae in Neutropenic Patients with Hematologic Malignancies
por: Satlin, Michael J., et al.
Publicado: (2014)

Genomic Characterization of ESBL- and Carbapenemase-Positive Enterobacteriaceae Co-harboring mcr-9 in Japan
por: Nakamura, Akihiro, et al.
Publicado: (2021)

Calculated parenteral initial treatment of bacterial infections: Infections with multi-resistant Gram-negative rods – ESBL producers, carbapenemase-producing Enterobacteriaceae, carbapenem-resistant Acinetobacter baumannii
por: Grabein, Béatrice, et al.
Publicado: (2020)

1885. Cost-Effectiveness of Ceftazidime–Avibactam Compared With Colistin for Treatment of Carbapenem-Resistant Enterobacteriaceae Bacteremia and Pneumonia
por: Sfeir, Maroun, et al.
Publicado: (2018)

Detection of ESBL among ampc producing enterobacteriaceae using inhibitor-based method
por: Bakthavatchalu, Sasirekha, et al.
Publicado: (2013)

CTX-M ESBL-producing Enterobacteriaceae: estimated prevalence in adults in England in 2014
por: McNulty, Cliodna A M, et al.
Publicado: (2018)

Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level
por: Woerther, Paul-Louis, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ifep8rui5kbvh3v1jelopgjo5e